Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation.

Robson, Mark

Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation. [electronic resource] - The New England journal of medicine 08 2017 - 523-533 p. digital

Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1533-4406

10.1056/NEJMoa1706450 doi


Adult
Aged
Antineoplastic Agents--adverse effects
Breast Neoplasms--drug therapy
Chemotherapy, Adjuvant
Disease-Free Survival
Female
Genes, BRCA1
Genes, BRCA2
Germ-Line Mutation
Humans
Kaplan-Meier Estimate
Middle Aged
Neoplasm Metastasis--drug therapy
Phthalazines--adverse effects
Piperazines--adverse effects
Poly(ADP-ribose) Polymerase Inhibitors--adverse effects
Receptor, ErbB-2
Young Adult